BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8675357)

  • 1. Low dose megestrol increases serum albumin in malnourished dialysis patients.
    Lien YH; Ruffenach SJ
    Int J Artif Organs; 1996 Mar; 19(3):147-50. PubMed ID: 8675357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of megestrol acetate on serum albumin level in malnourished dialysis patients.
    Monfared A; Heidarzadeh A; Ghaffari M; Akbarpour M
    J Ren Nutr; 2009 Mar; 19(2):167-71. PubMed ID: 19218044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results.
    Gołebiewska J; Lichodziejewska-Niemierko M; Aleksandrowicz E; Majkowicz M; Lysiak-Szydłowska W; Rutkowski B
    Acta Biochim Pol; 2009; 56(4):733-7. PubMed ID: 19997653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients.
    Rammohan M; Kalantar-Zadeh K; Liang A; Ghossein C
    J Ren Nutr; 2005 Jul; 15(3):345-55. PubMed ID: 16007564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients.
    Gołębiewska JE; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Majkowicz M; Lysiak-Szydłowska W; Rutkowski B
    Int Urol Nephrol; 2012 Aug; 44(4):1211-22. PubMed ID: 21805328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia.
    Eustace JA; Coresh J; Kutchey C; Te PL; Gimenez LF; Scheel PJ; Walser M
    Kidney Int; 2000 Jun; 57(6):2527-38. PubMed ID: 10844622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
    Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
    J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma lipoprotein(a) levels and hypoalbuminemia in peritoneal dialysis patients.
    Ross EA; Shah GM; Kashyap ML
    Int J Artif Organs; 1995 Dec; 18(12):751-6. PubMed ID: 8964640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of megestrol acetate on nutritional parameters in a dialysis population.
    Boccanfuso JA; Hutton M; McAllister B
    J Ren Nutr; 2000 Jan; 10(1):36-43. PubMed ID: 10671632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and hypoalbuminemia at initiation of hemodialysis as risk factor for survival of dialysis patients.
    Anees M; Ibrahim M
    J Coll Physicians Surg Pak; 2009 Dec; 19(12):776-80. PubMed ID: 20042156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing serum albumin in dialysis patients.
    Yeun JY; Kaysen GA
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S118-25. PubMed ID: 9892378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hypoalbuminemic hemodialysis patients with a modified regimen of oral essential amino acids.
    Bronich L; Te T; Shetye K; Stewart T; Eustace JA
    J Ren Nutr; 2001 Oct; 11(4):194-201. PubMed ID: 11679999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.
    Faller B; Aparicio M; Faict D; De Vos C; de Précigout V; Larroumet N; Guiberteau R; Jones M; Peluso F
    Nephrol Dial Transplant; 1995; 10(8):1432-7. PubMed ID: 8538938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of uraemic anorexia with megestrol acetate].
    Fernández Lucas M; Teruel JL; Burguera V; Sosa H; Rivera M; Rodríguez Palomares JR; Marcén R; Quereda C
    Nefrologia; 2010; 30(6):646-52. PubMed ID: 21113214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients.
    Ross EA; Koo LC
    Am J Kidney Dis; 1998 Jan; 31(1):62-6. PubMed ID: 9428453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate.
    Costero O; Bajo MA; del Peso G; Gil F; Aguilera A; Ros S; Hevia C; Selgas R
    Adv Perit Dial; 2004; 20():209-12. PubMed ID: 15384828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients.
    Davies SJ; Phillips L; Griffiths AM; Naish PF; Russell GI
    Kidney Int; 2000 Apr; 57(4):1743-54. PubMed ID: 10760111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality.
    Fernández E; Betriu MA; Gómez R; Montoliu J
    Nephrol Dial Transplant; 1996 Aug; 11(8):1559-63. PubMed ID: 8856211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
    Kotzmann H; Yilmaz N; Lercher P; Riedl M; Schmidt A; Schuster E; Kreuzer S; Geyer G; Frisch H; Hörl WH; Mayer G; Luger A
    Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.